CHANGES IN ELECTROPHYSIOLOGICAL AND MECHANICAL RESPONSES OF THE RAT PAPILLARY-MUSCLE TO ALPHA-AGONIST AND BETA-AGONIST IN STREPTOZOTOCIN-INDUCED DIABETES
K. Kamata et al., CHANGES IN ELECTROPHYSIOLOGICAL AND MECHANICAL RESPONSES OF THE RAT PAPILLARY-MUSCLE TO ALPHA-AGONIST AND BETA-AGONIST IN STREPTOZOTOCIN-INDUCED DIABETES, Canadian journal of physiology and pharmacology, 75(7), 1997, pp. 781-788
To clarify the changes occurring in diabetic animals in the responsive
ness of the myocardium to alpha(1)- and beta-adrenoceptor agonists, we
examined both alpha- and beta-adrenoceptor-mediated electrophysiologi
cal and mechanical responses in the depolarized right ventricular papi
llary muscle of streptozotocin (STZ) induced diabetic rats and age-mat
ched controls. Both methoxamine (10(-7)-10(-4) M) and isoproterenol (1
0(-9)-10(-6) M) enhanced the slow response action potential in a conce
ntration-dependent manner. The amplitude and the APD(50) (time require
d for 50% repolarization) of the methoxamine-induced slow response act
ion potential were both markedly increased in STZ-induced diabetic rat
s in comparison with control rats, whereas those of the isoproterenol-
induced slow response were significantly decreased. The methoxamine-in
duced contraction in depolarized muscle was slightly but not significa
ntly increased in STZ-induced diabetic rats, whereas the isoproterenol
-induced contractile response was significantly attenuated. The maximu
m number of binding sites (B-max) for [H-3]dihydroalprenolol and for [
H-3]prazosin were both significantly decreased in diabetic rats, compa
red with age-matched control rats, without any change in the affinity
constants. The slow response action potential induced by methoxamine b
ut not isoproterenol was attenuated by IAP (islet-activating factor) t
reatment (50 mu g/kg, i.v. for 3 days). These results suggest that an
a-adrenoceptor-mediated electrophysiological response is unmasked when
the P-adrenoceptor-mediated response is desensitized in the papillary
muscle of STZ-induced diabetic rats.